Rodulfo GM, Bosch CC, Vailliny HR, Noda ÁT, Escobar JJ

Language: Spanish
References: 19
Page: 1065-1075
PDF size: 1161.45 Kb.

ABSTRACT

Introduction: The diabetes mellitus and ischemic heart disease are closely related, since patients with the former have more risk of presenting the latter, as well as higher cardiovascular mortality.
Objective: To identify the postoperative complications in patients with type II diabetes mellitus.
Method: A serial cases descriptive study of 203 patients with type II diabetes mellitus, exposed to coronary revascularization surgery was carried out in the Heart Center of Saturnino Lora Teaching Provincial Hospital Hospital in Santiago de Cuba, from January, 2011 to the same period in 2020.
Results: In the case material the male sex (56.1 %) and the 45 - 64 age group (53.7 %) were more affected, who had more than 10 years with the endocrine disease and the ischemic heart disease had been detected in the latter, with an acute form of presentation. Several risk factors were found, such as diffuse coronary disease, glycemia high levels in the perioperative period and low left ventricular fraction. In most of the surgical interventions the heart beating technique was used (81.8 %), and the predominant complications were supraventricular arrhythmias, low heart output and infections of the wound.
Conclusions: The surgery of coronary in patients with type II diabetes mellitus is the method that achieves a more complete revascularization, either anatomical as functional, and the heart beating technique reduces the mortality, although the complications attributable to multifactorial causes are still frequent.

REFERENCES

1. Mcguire DK, Inzucchi SE, Marx N. Diabetes y sistema cardiovascular. En: Braunwald. Tratado de Medicina Cardiovascular. 11ed. Philadelphia: Elsevier - Saunders; 2019. p. 1007-27.

2. International Diabetes Federation. IDF Diabetes Atlas - 8th Edition; 2017 ?citado 08/12/2020?. Disponible en: https://diabetesatlas.org/upload/resources/previous/files/8/IDF_DA_8e-EN-final.pdf

3. Prospective Studies Collaboration and Asia Pacific Cohort Studies Collaboration. Sex - specific relevance of diabetes to occlusive vascular and other mortality: a collaborative meta - analysis of individual data from 980 793 adults from 68 prospective studies. Lancet Diabetes Endocrinol. 2018; 6:538-546.

4. Cuba. Ministerio de Salud Pública. Dirección de Registros Médicos y Estadísticas de Salud. Anuario Estadístico de Salud. 2019. La Habana: MINSAP; 2019.

5. Lean MEJ, Leslie WS, Barnes AC, Brosnahan N, Thom G, McCombie L, et al. Durability of a primary care-led weight-management intervention for remission of type 2 diabetes: 2 - year results of the DiRECT open - label, cluster - randomised trial. Lancet Diabetes Endocrinol. 2019; 7 (5): 344-55.

6. Armstrong EJ, Rutledge JC, Rogers JH. Coronary artery revascularization in patients with diabetes mellitus. Circulation. 2013; 128 (15): 1675 - 85.

7. Vistisen D, Witte DR, Brunner EJ, Kivimaki M, Tabák A, Jorgensen ME, et al. Risk of cardiovascular disease and death in individuals with prediabetes defined by different criteria: the Whitehall II study. Diabetes Care. 2018; 41 (4): 899-906.

8. Cid Álvarez AB, Rodríguez Leor O, Moreno R, Pérez de Prado A. Registro Español de hemodinámica y Cardiología Intervencionista. XXVII Informe Oficial de la Sección de Hemodinámica y Cardiología Intervencionista de la Sociedad Española de Cardiología (1990-2017). Rev Esp Cardiol. 2018 ?citado 15/09/2018?; 71 (12). Disponible en: https://www.revespcardiol.org/es-registro-espanol-hemodinamica-cardiologia-intervencionista--articulo-S030089321830441X?referer=registros

9. Barry E, Roberts S, Oke J, Vijayaraghavan S, Normansell R, Greenhalgh T. Efficacy and effectiveness of screen and treat policies in prevention of type 2 diabetes: systematic review and meta-analysis of screening tests and interventions. BMJ. 2017;356: i6538.

10. Rodulfo García M. Influencia de la diabetes mellitus en la cirugía de revascularización coronaria. MEDISAN. 2012 ?citado 12/07/2020?; 16 (10): 1611. Disponible en: https://www.redalyc.org/articulo.oa?id=368448459016

11. Grupo de Trabajo de la SEC para la guía ESC/EACTS 2018 sobre revascularización miocárdica. Revisores expertos para la guía ESC/EACTS 2017 sobre revascularización miocárdica. Comentarios a la guía ESC/EACTS 2018 sobre revascularización miocárdica. Rev Esp Cardiol. 2019;72(1): 16-20.

12. Arnold SV, Bhatt DL, Barsness GW, Beatty AL, Deedwania PC, Inzucchi SE, et al. Clinical management of stable coronary disease in patients with type 2 diabetes mellitus: A scientific statement from the American Heart Association. Circulation. 2020; 141(19): e779-e806.

13. Cosentino F, Grant PJ, Aboyans V, Bailey CJ, Ceriello A, Delgado V, et al. Guía ESC 2019 sobre diabetes, prediabetes y enfermedad cardiovascular en colaboración con la European Association for the study of diabetes (EASD). Rev Esp Cardiol. 2020; 73 (5): 404.e1- 404.e59.

14. American Diabetes Association. 2 Classification and diagnosis of diabetes: Standards of Medical Care in Diabetes-2019. Diabetes Care. 2019; 42 (supplement 1): S13-S28.

15. Bangalore S, Guo Y, Samadashvili Z, Blecker S, Hannan EL. Revascularization in patients with multivessel coronary artery disease and severe left ventricular systolic dysfunction: Everolimus-eluting stents versus coronary artery bypass graft surgery. Circulation. 2016; 133:2132-40.

16. Giorgi M, Litwak L. Consenso de Enfermedad Cardiovascular y Diabetes - 2019. Área de consensos y normas. Azcuénaga: Sociedad Argentina de Cardiología; 2019.

17. Neumann FJ, Sousa Uva M, Ahlsson A, Alfonso F, Banning AP, Benedetto U, et al. Guía ESC/EACTS 2018 sobre revascularización miocárdica. Rev Esp Cardiol. 2019; 72(1):73. e1-e76.

18. Velázquez EJ, Lee KL, Jones RH, Al-Khalidi HR, Hill JA, Panza JA, et al. Coronary-artery bypass surgery in patients with ischemic cardiomyopathy. N Engl J Med. 2016; 374 (16):1511-20.

19. Gong Q, Zhang P, Wang J, Ma J, An Y, Chen Y, et al. Diabetes Prevention Study Group. Morbidity and mortality after lifestyle intervention for people with impaired glucose tolerance: 30-year results of the Da Qing Diabetes Prevention Outcome Study. Lancet Diabetes Endocrinol. 2019; 7:452- 61.